4 interactions with chain G,
1 Ligand-Water interactions
Metal complexes:
G:T.17,
G:Y.128,
G:R.131,
G:M.134,
H2O.2
MG.4:
4
residues within 4Å:
Chain I:
A.175,
D.178,
S.181,
D.205
3 PLIP interactions:
3 interactions with chain I
Metal complexes:
I:A.175,
I:D.178,
I:S.181
MG.7:
6
residues within 4Å:
Chain K:
A.164,
H.165,
D.167,
A.168,
S.170
Chain W:
D.205
4 PLIP interactions:
1 interactions with chain W,
3 interactions with chain K
Metal complexes:
W:D.205,
K:A.164,
K:D.167,
K:S.170
MG.11:
5
residues within 4Å:
Chain 0:
L.47
Chain N:
R.18,
I.162,
D.165,
S.168
3 PLIP interactions:
3 interactions with chain N
Metal complexes:
N:I.162,
N:D.165,
N:S.168
MG.14:
4
residues within 4Å:
Chain W:
A.175,
D.178,
S.181,
D.205
3 PLIP interactions:
3 interactions with chain W
Metal complexes:
W:A.175,
W:D.178,
W:S.181
MG.15:
3
residues within 4Å:
Chain X:
Q.118,
D.120,
T.124
No protein-ligand interaction detected (PLIP)
MG.18:
6
residues within 4Å:
Chain I:
D.205
Chain Y:
A.164,
H.165,
D.167,
A.168,
S.170
4 PLIP interactions:
3 interactions with chain Y,
1 interactions with chain I
Metal complexes:
Y:A.164,
Y:D.167,
Y:S.170,
I:D.205
MG.19:
6
residues within 4Å:
Chain Z:
R.28,
T.192,
H.195,
I.196,
V.198,
D.222
2 PLIP interactions:
2 interactions with chain Z
Metal complexes:
Z:T.192,
Z:V.198
4 x
01:
azanylidene-[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(1S)-2-cyclohexyl-1-[(2R,3S,6R,7S)-3-methanoyl-2,6-dimethyl-6,7-bis(oxidanyl)-1,4-oxazepan-7-yl]ethyl]amino]-1-oxidanylidene-hexan-2-yl]carbamoyl]-4,4-bis(fluoranyl)pyrrolidin-1-yl]-1-oxidanylidene-propan-2-yl]amino]-2-oxidanylidene-ethyl]imino-azanium
Maurits, E. et al., Structure-based design of peptide epoxyketones selectively targeting the three human immunoproteasome active sites. To Be Published
